Position in UTHR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$472,475
+$128,547 QoQ
Shares Held
872
+50.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#584
of 870 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VestGen Advisors, LLC holds $14,196,270 across 7 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
707,099 | $11,228,732 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
26,623 | $901,987 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
34,961 | $860,390 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
872 | $472,475 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,368 | $399,102 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
5,774 | $200,184 | |
| 7 | HLN |
Haleon plc
|
14,298 | $133,400 |
All Filings in UTHR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $472,475 | 872 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $343,928 | 580 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||